As a part of our FDA Series, Reed Smith will be hosting an upcoming webinar, “The changing regulatory landscape of promotion: Drug/biologic advertising in the Trump era and beyond” on Thursday, September 19, 2019 at 2:00 PM ET.
This program will discuss promotional enforcement activity under the Trump Administration and how recent technological, demographic, and other developments are altering the landscape of drug and biologic promotion in the United States. In addition, we will take a closer look the new channels of advertising available to drug and biologic companies and their accompanying regulatory challenges.
Please click here to register for the webinar.